News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Results>SIHUAN PHARM 2025 Swings into Profit of RMB180M; Final DPS RMB0.96 Cents
SIHUAN PHARM (00460.HK) announced its annual results for the year ended 31 December 2025, with a turnover of RMB2.618 billion, up 37.7% YoY. Profit amounted to RMB180 million, repr...
Reset
Send
The window will close in 5 seconds
<Results>SIHUAN PHARM 2025 Swings into Profit of RMB180M; Final DPS RMB0.96 Cents
Close
Recommend
18
Positive
20
Negative
8
 
 

SIHUAN PHARM (00460.HK)  -0.040 (-2.759%)    Short selling $7.55M; Ratio 54.367%   announced its annual results for the year ended 31 December 2025, with a turnover of RMB2.618 billion, up 37.7% YoY. Profit amounted to RMB180 million, representing a turnaround from a loss of RMB217 million in the same period of 2024.

Dividend History
Announce DateEventParticular
2025/09/04SpecialPreferential Offer: Assured entitlement 1 XuanZhu Biopharmaceutical Co., Ltd. reserved share for every integral multiple of 2728 shares
2025/08/29InterimD:RMB 0.0099 (Equivalent to approximately HKD 0.0109)
2025/03/28FinalNo Dividend
2024/08/30InterimD:RMB 0.0190 (Equivalent to approximately HKD 0.021)

EPS were RMB1.97 cents. A final DPS of RMB0.96 cents was declared, compared with nil dividend in the same period last year.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.